NCT06596018View on ClinicalTrials.gov

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

December 25, 2024

Primary Completion Date

September 20, 2027

Study Completion Date

September 20, 2028

Conditions
Breast Adenocarcinoma
Interventions
RADIATION

SBRT

Target the primary tumor region with a single dose of 8Gy using 6MV-X rays, administered once a day for three consecutive days.

DRUG

Chemotherapy

Continue to follow the original chemotherapy regimen（anthracycline and/or taxane based regimens）

Trial Locations (1)

Unknown

RECRUITING

The Department of Radiation Oncology，the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER